Peer review reports
From: Biomarker analysis of cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric and oesophago-gastric junction cancer: results from a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO)
Original Submission |
1 Nov 2011 |
Submitted |
Original manuscript
|
15 Nov 2011 |
Author responded |
Author comments - Birgit Luber
|
Resubmission - Version 2 |
15 Nov 2011 |
Submitted |
Manuscript version 2
|
Resubmission - Version 3 |
|
Submitted |
Manuscript version 3
|
Resubmission - Version 4 |
|
Submitted |
Manuscript version 4
|
6 Dec 2011 |
Author responded |
Author comments - Birgit Luber
|
Resubmission - Version 5 |
6 Dec 2011 |
Submitted |
Manuscript version 5
|
Publishing |
7 Dec 2011 |
Editorially accepted |
|
7 Dec 2011 |
Article published |
10.1186/1471-2407-11-509
|
Learn about peer review